Background: In southern Europe, the risk of cancer in patients with end-stage kidney disease receiving dialysis has not been well quantified. The aim of this study was to assess the overall pattern of risk for de novo malignancies (DNMs) among dialysis patients in the Friuli Venezia Giulia region, north-eastern Italy.Methods: A population-based cohort study among 3407 dialysis patients was conducted through a record linkage between local healthcare databases and the cancer registry (1998-2013). Person-years (PYs) were calculated from 30 days after the date of first dialysis to the date of DNM diagnosis, kidney transplant, death, last follow-up or December 31, 2013, whichever came first. The risk of DNM, as compared to the general population, was estimated using standardized incidence ratios (SIRs) and 95% confidence intervals (CIs).Results: During 10,798 PYs, 357 DNMs were diagnosed in 330 dialysis patients. A higher than expected risk of 1.3-fold was found for all DNMs combined (95% CI: 1.15-1.43). The risk was particularly high in younger dialysis patients (SIR = 1.88, 95% CI: 1.42-2.45 for age 40-59 years), and it decreased with age. Moreover, significantly increased DNM risks emerged during the first 3 years since dialysis initiation, especially within the first year (SIR = 8.52, 95% CI: 6.89-10.41). Elevated excess risks were observed for kidney (SIR = 3.18; 95% CI: 2.06-4.69), skin non-melanoma (SIR = 1.81, 95% CI: 1.46-2.22), oral cavity (SIR = 2.42, 95% CI: 1.36-4.00), and Kaposi's sarcoma (SIR = 10.29, 95% CI: 1.25-37.16).Conclusions: The elevated risk for DNM herein documented suggest the need to implement a targeted approach to cancer prevention and control in dialysis patients.

Taborelli, M., Toffolutti, F., Del Zotto, S., Clagnan, E., Furian, L., Piselli, P., et al. (2019). Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy. BMC NEPHROLOGY, 20(1), 107 [10.1186/s12882-019-1283-4].

Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy

Zanini S.;Rendina M.;Toti L.;Tisone G.;Sforza D.;Iaria G.;Belardi C.;Montalbano M.;Di Leo L.;Spagnoletti G.;Biancone L.;Maresca M. C.;
2019-01-01

Abstract

Background: In southern Europe, the risk of cancer in patients with end-stage kidney disease receiving dialysis has not been well quantified. The aim of this study was to assess the overall pattern of risk for de novo malignancies (DNMs) among dialysis patients in the Friuli Venezia Giulia region, north-eastern Italy.Methods: A population-based cohort study among 3407 dialysis patients was conducted through a record linkage between local healthcare databases and the cancer registry (1998-2013). Person-years (PYs) were calculated from 30 days after the date of first dialysis to the date of DNM diagnosis, kidney transplant, death, last follow-up or December 31, 2013, whichever came first. The risk of DNM, as compared to the general population, was estimated using standardized incidence ratios (SIRs) and 95% confidence intervals (CIs).Results: During 10,798 PYs, 357 DNMs were diagnosed in 330 dialysis patients. A higher than expected risk of 1.3-fold was found for all DNMs combined (95% CI: 1.15-1.43). The risk was particularly high in younger dialysis patients (SIR = 1.88, 95% CI: 1.42-2.45 for age 40-59 years), and it decreased with age. Moreover, significantly increased DNM risks emerged during the first 3 years since dialysis initiation, especially within the first year (SIR = 8.52, 95% CI: 6.89-10.41). Elevated excess risks were observed for kidney (SIR = 3.18; 95% CI: 2.06-4.69), skin non-melanoma (SIR = 1.81, 95% CI: 1.46-2.22), oral cavity (SIR = 2.42, 95% CI: 1.36-4.00), and Kaposi's sarcoma (SIR = 10.29, 95% CI: 1.25-37.16).Conclusions: The elevated risk for DNM herein documented suggest the need to implement a targeted approach to cancer prevention and control in dialysis patients.
2019
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/18 - CHIRURGIA GENERALE
English
Cancer risk; Dialysis; End-stage kidney disease; Italy; Population-based study; de novo malignancies; Adult; Aged; Cohort Studies; Female; Follow-Up Studies; Humans; Italy; Kidney Failure, Chronic; Male; Middle Aged; Neoplasms; Registries; Renal Dialysis; Risk Factors; Population Surveillance
Taborelli, M., Toffolutti, F., Del Zotto, S., Clagnan, E., Furian, L., Piselli, P., et al. (2019). Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy. BMC NEPHROLOGY, 20(1), 107 [10.1186/s12882-019-1283-4].
Taborelli, M; Toffolutti, F; Del Zotto, S; Clagnan, E; Furian, L; Piselli, P; Citterio, F; Zanier, L; Boscutti, G; Serraino, D; Shalaby, S; Petrara, R; Burra, P; Zanus, G; Zanini, S; Rigotti, P; Rendina, M; Di Leo, A; Schena, Fp; Grandaliano, G; Fiorentino, M; Lauro, A; Pinna, Ad; Di Gioia, P; Pellegrini, S; Zanfi, C; Scolari, Mp; Stefoni, S; Todeschini, P; Panicali, L; Valentini, C; Baccarani, U; Risaliti, A; Adani, Gl; Lorenzin, D; Ettorre, Gm; Vennarecci, G; Colasanti, M; Coco, M; Ettorre, F; Santoro, R; Miglioresi, L; Nudo, F; Rossi, M; Mennini, G; Toti, L; Tisone, G; Casella, A; Fazzolari, L; Sforza, D; Iaria, G; Gazia, C; Belardi, C; Cimaglia, C; Agresta, A; D'Offizi, G; Comandini, Uv; Lionetti, R; Montalbano, M; Taibi, C; Fantola, G; Zamboni, F; Piredda, Gb; Michittu, Mb; Murgia, Mg; Onano, B; Fratino, L; Maso, Ld; De Paoli, P; Verdirosi, D; Vaccher, E; Pisani, F; Famulari, A; Delreno, F; Iesari, S; De Luca, L; Iaria, M; Capocasale, E; Cremaschi, E; Sandrini, S; Valerio, F; Mazzucotelli, V; Bossini, N; Setti, G; Veroux, M; Veroux, P; Giaquinta, A; Zerbo, D; Busnach, G; Di Leo, L; Perrino, Ml; Querques, M; Colombo, V; Sghirlanzoni, Mc; Messa, P; Leoni, A; Galatioto, L; Gruttadauria, S; Sparacino, V; Caputo, F; Buscemi, B; Spagnoletti, G; Salerno, Mp; Favi, E; Segoloni, Gp; Biancone, L; Lavacca, A; Maresca, Mc; Cascone, C; Virgilio, B; Donati, D; Dossi, F; Fontanella, A; Ambrosini, A; Di Cicco, M
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/241513
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 22
social impact